{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T14:32:45Z","timestamp":1783780365534,"version":"3.55.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Chugai Pharmaceutical Co. Ltd."}],"content-domain":{"domain":["jrnjournal.org","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Renal Nutrition"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1053\/j.jrn.2016.06.004","type":"journal-article","created":{"date-parts":[[2016,7,28]],"date-time":"2016-07-28T16:04:02Z","timestamp":1469721842000},"page":"380-390","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Intravenous Vitamin B6 Increases Resistance to Erythropoiesis-Stimulating Agents in Hemodialysis Patients: A Randomized Controlled Trial"],"prefix":"10.1053","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7032-4383","authenticated-orcid":false,"given":"Yoshitsugu","family":"Obi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Mikami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Hamano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasue","family":"Obi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotaka","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Shimomura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromi","family":"Rakugi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshitaka","family":"Isaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.jrn.2016.06.004_bib1","series-title":"Present knowledge in nutrition","first-page":"307","article-title":"Vitamin B6","author":"da Silva","year":"2012"},{"key":"10.1053\/j.jrn.2016.06.004_bib2","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1093\/ajcn\/87.5.1446","article-title":"Plasma pyridoxal 5'-phosphate in the US population: the National Health and Nutrition Examination Survey, 2003-2004","volume":"87","author":"Morris","year":"2008","journal-title":"Am J Clin Nutr"},{"key":"10.1053\/j.jrn.2016.06.004_bib3","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3945\/ajcn.2009.28571","article-title":"Association of vitamin B-6 status with inflammation, oxidative stress, and chronic inflammatory conditions: The boston puerto rican health study","volume":"91","author":"Shen","year":"2010","journal-title":"Am J Clin Nutr"},{"key":"10.1053\/j.jrn.2016.06.004_bib4","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.freeradbiomed.2003.09.012","article-title":"Effect of vitamin B6 on oxygen radicals, mitochondrial membrane potential, and lipid peroxidation in H2O2-treated u937 monocytes","volume":"36","author":"Kannan","year":"2004","journal-title":"Free Radic Biol Med"},{"key":"10.1053\/j.jrn.2016.06.004_bib5","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.3945\/jn.111.153056","article-title":"Plasma pyridoxal-5-phosphate is inversely associated with systemic markers of inflammation in a population of U.S. Adults","volume":"142","author":"Sakakeeny","year":"2012","journal-title":"J Nutr"},{"key":"10.1053\/j.jrn.2016.06.004_bib6","doi-asserted-by":"crossref","first-page":"25702","DOI":"10.3402\/fnr.v59.25702","article-title":"Role of vitamin b6 status on antioxidant defenses, glutathione, and related enzyme activities in mice with homocysteine-induced oxidative stress","volume":"59","author":"Hsu","year":"2015","journal-title":"Food Nutr Res"},{"key":"10.1053\/j.jrn.2016.06.004_bib7","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.freeradbiomed.2008.11.002","article-title":"Homocysteine and inflammation as main determinants of oxidative stress in the elderly","volume":"46","author":"Ventura","year":"2009","journal-title":"Free Radic Biol Med"},{"key":"10.1053\/j.jrn.2016.06.004_bib8","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1475-2891-14-6","article-title":"Role of homocysteine in the development of cardiovascular disease","volume":"14","author":"Ganguly","year":"2015","journal-title":"Nutr J"},{"key":"10.1053\/j.jrn.2016.06.004_bib9","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1042\/BJ20061386","article-title":"Elevated oxidative stress in erythrocytes due to a SOD1 deficiency causes anaemia and triggers autoantibody production","volume":"402","author":"Iuchi","year":"2007","journal-title":"Biochem J"},{"key":"10.1053\/j.jrn.2016.06.004_bib10","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1515\/CCLM.2007.362","article-title":"The role of hyperhomocysteinemia as well as folate, vitamin B(6) and B(12) deficiencies\u00a0in\u00a0osteoporosis: a systematic review","volume":"45","author":"Herrmann","year":"2007","journal-title":"Clin Chem Lab Med"},{"key":"10.1053\/j.jrn.2016.06.004_bib11","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1161\/01.CIR.94.11.2743","article-title":"Hyperhomocysteinemia confers an independent increased risk of atherosclerosis in end-stage renal disease and is closely linked to plasma folate and pyridoxine concentrations","volume":"94","author":"Robinson","year":"1996","journal-title":"Circulation"},{"key":"10.1053\/j.jrn.2016.06.004_bib12","doi-asserted-by":"crossref","first-page":"S89","DOI":"10.1053\/ajkd.2003.50093","article-title":"Hyperhomocysteinemia and its relationship to cardiovascular disease in ESRD: influence of hypoalbuminemia, malnutrition, inflammation, and diabetes mellitus","volume":"41","author":"Suliman","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.jrn.2016.06.004_bib13","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1093\/ndt\/18.1.106","article-title":"Homocysteine, c-reactive protein, lipid peroxidation, and mortality in haemodialysis patients","volume":"18","author":"Bayes","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.jrn.2016.06.004_bib14","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1093\/eurheartj\/ehs205","article-title":"The role of the kidney in heart failure","volume":"33","author":"Metra","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1053\/j.jrn.2016.06.004_bib15","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.1097\/01.ASN.0000093240.84097.FE","article-title":"Novel cardiovascular risk factors in end-stage renal disease","volume":"15 Suppl 1","author":"Zoccali","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.jrn.2016.06.004_bib16","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1053\/j.jrn.2011.10.031","article-title":"Role of uremic toxins and oxidative stress in the development of chronic kidney disease-mineral and bone disorder","volume":"22","author":"Tanaka","year":"2012","journal-title":"J Ren Nutr"},{"key":"10.1053\/j.jrn.2016.06.004_bib17","first-page":"S1","article-title":"KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD)","volume":"76","year":"2009","journal-title":"Kidney Int Suppl"},{"key":"10.1053\/j.jrn.2016.06.004_bib18","doi-asserted-by":"crossref","first-page":"4385","DOI":"10.1093\/ndt\/gfs297","article-title":"Association between serum 25-hydroxyvitamin D and nephrolithiasis: the national health and nutrition\u00a0examination survey III, 1988-94","volume":"27","author":"Tang","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.jrn.2016.06.004_bib19","first-page":"619","article-title":"Is vitamin B(6) deficiency an under-recognized risk in patients receiving haemodialysis? A systematic review: 2000-2010","volume":"16","author":"Corken","year":"2011","journal-title":"Nephrology (Carlton)"},{"key":"10.1053\/j.jrn.2016.06.004_bib20","first-page":"975","article-title":"Effects of high-dose vitamin b6 therapy on microcytic and hypochromic anemia in hemodialysis patients","volume":"35","author":"Toriyama","year":"1993","journal-title":"Nihon Jinzo Gakkai Shi"},{"key":"10.1053\/j.jrn.2016.06.004_bib21","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1016\/0024-3205(88)90484-5","article-title":"Inhibitory effects of pyridoxal phosphate, ascorbate and aminoguanidine on nonenzymatic glycosylation","volume":"43","author":"Khatami","year":"1988","journal-title":"Life Sci"},{"key":"10.1053\/j.jrn.2016.06.004_bib22","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1038\/ki.1993.185","article-title":"Water soluble vitamins in chronic hemodialysis patients and need for supplementation","volume":"43","author":"Descombes","year":"1993","journal-title":"Kidney Int"},{"key":"10.1053\/j.jrn.2016.06.004_bib23","first-page":"S56","article-title":"Metabolism of vitamin B6 and its requirement in chronic renal failure","volume":"62","author":"Mydlik","year":"1997","journal-title":"Kidney Int Suppl"},{"key":"10.1053\/j.jrn.2016.06.004_bib24","first-page":"ii45","article-title":"EBPG guideline on nutrition","volume":"22 Suppl 2","author":"Fouque","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.jrn.2016.06.004_bib25","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1681\/ASN.2005090997","article-title":"Associations between changes in hemoglobin and administered erythropoiesis-stimulating agent\u00a0and survival in hemodialysis patients","volume":"17","author":"Regidor","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.jrn.2016.06.004_bib26","doi-asserted-by":"crossref","first-page":"S75","DOI":"10.1038\/ki.2008.523","article-title":"Factors that condition the response to erythropoietin in patients on hemodialysis and their relation to mortality","volume":"74","author":"Lopez-Gomez","year":"2008","journal-title":"Kidney Int Suppl"},{"key":"10.1053\/j.jrn.2016.06.004_bib27","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1053\/j.ajkd.2011.07.014","article-title":"Erythropoiesis-stimulating agent responsiveness and mortality in hemodialysis patients: results from a cohort study from the dialysis registry in Japan","volume":"59","author":"Fukuma","year":"2012","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.jrn.2016.06.004_bib28","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0272-6386(99)70259-3","article-title":"Acute-phase response predicts erythropoietin resistance in hemodialysis and peritoneal dialysis patients","volume":"33","author":"Gunnell","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.jrn.2016.06.004_bib29","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/1744-9987.12088","article-title":"Effect of switching to nocturnal thrice-weekly hemodialysis on clinical and laboratory parameters: our experience","volume":"17","author":"Gubensek","year":"2013","journal-title":"Ther Apher Dial"},{"key":"10.1053\/j.jrn.2016.06.004_bib30","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1744-9987.2010.00836.x","article-title":"2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease","volume":"14","author":"Tsubakihara","year":"2010","journal-title":"Ther Apher Dial"},{"key":"10.1053\/j.jrn.2016.06.004_bib31","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1248\/yakushi1947.98.10_1319","article-title":"Simultaneous determination of vitamin b6 group in blood by high-performance liquidchromatography (hplc)(author's transl)","volume":"98","author":"Yoshida","year":"1978","journal-title":"Yakugaku zasshi"},{"key":"10.1053\/j.jrn.2016.06.004_bib32","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1053\/ajkd.2002.29904","article-title":"Vitamin B6 metabolism and homocysteine in end-stage renal disease and chronic renal insufficiency","volume":"39","author":"Lindner","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.jrn.2016.06.004_bib33","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1093\/jn\/120.suppl_11.1503","article-title":"Vitamin B-6: A status report","volume":"120 Suppl 11","author":"Leklem","year":"1990","journal-title":"J Nutr"},{"key":"10.1053\/j.jrn.2016.06.004_bib34","series-title":"Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline","year":"1998"},{"key":"10.1053\/j.jrn.2016.06.004_bib35","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.jclinepi.2011.07.011","article-title":"The size of a pilot study for a clinical trial should be calculated in relation to considerations of precision and efficiency","volume":"65","author":"Sim","year":"2012","journal-title":"J Clin Epidemiol"},{"key":"10.1053\/j.jrn.2016.06.004_bib36","series-title":"Multilevel and Longitudinal Modeling Using Stata","author":"Rabe-Hesketh","year":"2012"},{"key":"10.1053\/j.jrn.2016.06.004_bib37","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1056\/NEJM198308253090801","article-title":"Sensory neuropathy from pyridoxine abuse. A new megavitamin syndrome","volume":"309","author":"Schaumburg","year":"1983","journal-title":"N Engl J Med"},{"key":"10.1053\/j.jrn.2016.06.004_bib38","series-title":"Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline","year":"1998"},{"key":"10.1053\/j.jrn.2016.06.004_bib39","series-title":"Nutrition Management of Renal Disease","first-page":"351","article-title":"Vitamin metabolism and requirements in renal disease and renal failure","author":"Chazot","year":"2013"},{"key":"10.1053\/j.jrn.2016.06.004_bib40","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/ajcn\/88.1.140","article-title":"Relation between pyridoxal and pyridoxal phosphate concentrations in plasma, red cells, and white cells in patients with critical illness","volume":"88","author":"Vasilaki","year":"2008","journal-title":"Am J Clin Nutr"},{"key":"10.1053\/j.jrn.2016.06.004_bib41","first-page":"3951","article-title":"Alkaline phosphatase (ec 3.1.3.1) in serum is inhibited by physiological concentrations of inorganic phosphate","volume":"83","author":"Coburn","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.jrn.2016.06.004_bib42","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1159\/000045938","article-title":"Vitamin B(6) therapy does not improve hematocrit in hemodialysis patients supplemented with iron and erythropoietin","volume":"87","author":"Weissgarten","year":"2001","journal-title":"Nephron"},{"key":"10.1053\/j.jrn.2016.06.004_bib43","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1056\/NEJMoa060900","article-title":"Homocysteine lowering with folic acid and b vitamins in vascular disease","volume":"354","author":"Lonn","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1053\/j.jrn.2016.06.004_bib44","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1001\/jama.300.7.795","article-title":"Mortality and cardiovascular events in patients treated with homocysteine-lowering b vitamins after coronary angiography: a randomized controlled trial","volume":"300","author":"Ebbing","year":"2008","journal-title":"JAMA"},{"key":"10.1053\/j.jrn.2016.06.004_bib45","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1001\/jama.298.10.1163","article-title":"Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomized controlled trial","volume":"298","author":"Jamison","year":"2007","journal-title":"JAMA"},{"key":"10.1053\/j.jrn.2016.06.004_bib46","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1001\/jama.2010.490","article-title":"Effect of b-vitamin therapy on progression of diabetic nephropathy: a randomized controlled trial","volume":"303","author":"House","year":"2010","journal-title":"JAMA"},{"key":"10.1053\/j.jrn.2016.06.004_bib47","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1056\/NEJMoa055227","article-title":"Homocysteine lowering and cardiovascular events after acute myocardial infarction","volume":"354","author":"Bonaa","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1053\/j.jrn.2016.06.004_bib48","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1001\/jama.2015.2274","article-title":"Efficacy of folic acid therapy in primary prevention of stroke among adults with hypertension in China: The CSPPT randomized clinical trial","volume":"313","author":"Huo","year":"2015","journal-title":"JAMA"},{"key":"10.1053\/j.jrn.2016.06.004_bib49","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.2215\/CJN.10091110","article-title":"Bone alkaline phosphatase and\u00a0mortality in dialysis patients","volume":"6","author":"Drechsler","year":"2011","journal-title":"Clin J Am Soc Nephrol"}],"container-title":["Journal of Renal Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1051227616300541?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1051227616300541?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,11]],"date-time":"2019-09-11T17:57:02Z","timestamp":1568224622000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1051227616300541"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":49,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["S1051227616300541"],"URL":"https:\/\/doi.org\/10.1053\/j.jrn.2016.06.004","relation":{},"ISSN":["1051-2276"],"issn-type":[{"value":"1051-2276","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intravenous Vitamin B6 Increases Resistance to Erythropoiesis-Stimulating Agents in Hemodialysis Patients: A Randomized Controlled Trial","name":"articletitle","label":"Article Title"},{"value":"Journal of Renal Nutrition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.jrn.2016.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1053\/j.jrn.2016.09.001","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 by the National Kidney Foundation, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}